Resources from the same session
1317MO - Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients
Presenter: Aikaterini Fameli
Session: Mini Oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1319MO - Actual patient access to innovative medicines in six European countries
Presenter: Julie Vancoppenolle
Session: Mini Oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1320MO - New oncologic drugs since 2010: Differences in approval and access between the United States, Europe and Brazil
Presenter: Rafael Barreto
Session: Mini Oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1321MO - Relevance index by cancer type: Trends and regional variation analysis, 2016-2020, Republic of Korea
Presenter: jeehee pyo
Session: Mini Oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1322MO - Selection of a set of quality indicators (QIs) on the care pathway in onco-hematology using a panel of experts
Presenter: Mario di Palma
Session: Mini Oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1318MO - Time to diagnosis among patients with cancer in the US
Presenter: Matthew Gitlin
Session: Mini Oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
Invited Discussant 1321MO, 1322MO and 1318MO
Presenter: Felipe Roitberg
Session: Mini Oral session: Policy and preventive strategies
Resources:
Slides
Webcast